Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000185323 | SCV000238203 | likely benign | not specified | 2018-02-28 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Labcorp Genetics |
RCV000231783 | SCV000286448 | uncertain significance | Dilated cardiomyopathy 1G; Autosomal recessive limb-girdle muscular dystrophy type 2J | 2017-12-06 | criteria provided, single submitter | clinical testing | |
CHEO Genetics Diagnostic Laboratory, |
RCV001170873 | SCV001333495 | likely benign | Cardiomyopathy | 2022-11-10 | criteria provided, single submitter | clinical testing | |
Revvity Omics, |
RCV003137753 | SCV003826556 | uncertain significance | not provided | 2021-12-09 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV004734826 | SCV005352868 | uncertain significance | TTN-related disorder | 2024-04-02 | no assertion criteria provided | clinical testing | The TTN c.14662C>G variant is predicted to result in the amino acid substitution p.Pro4888Ala. To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.011% of alleles in individuals of European (Non-Finnish) descent in gnomAD. At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. |